BLAU3 · Blau Farmaceutica SA
12.61
BRLUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
R$2.94B
PE
11.00
EV/EBITDA
8.2
DIV Yield
7.3%
Payout Ratio
80%
MQV Rating
4Weak
As at 09/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- EMA 125 Breakup
- Extreme Overbought
- HALO 200
- HALO All
- HALO Balance Sheet
- HALO Small
- Near Resistance
Key Fundamentals
EPS 3 yr Growth
-36.90%
EBITDA Margin
23.10%
Operating Cashflow
$222m
Free Cash Flow Return
8.50%
ROIC
11.30%
Interest Coverage
5.30
Quick Ratio
1.60
Performance
52 weeks range
Low 8.28 - 12.89
Trade Value (12mth)
US$179,321.00
1 week
16.54%
1 month
23.87%
YTD
17.85%
1 year
26.2%
All time high
42.25
Additional Data
Shares Outstanding (Fully Diluted)
229m
HALO Sector
Healthcare
Next Company Report Date
23-Mar-27
Next Ex Dividend Date
19-Dec-25
Next Dividend Pay Date
19-Dec-25
Reporting Currency
BRL
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Weak
Mqv Small
Weak
Momentum
Price
Strong
Earnings
Neutral
Growth
Earnings
Neutral
Dividends
Very Weak
Quality
Capital Efficiency
Neutral
Balance Sheet
Very Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Marcelo Rodolfo Hahn | Individual |
| Blau Farmacêutica SA | Public Company |
